Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk

Middle East tensions escalated as the UAE reported Iranian missile and drone attacks, the U.S. reportedly sank six Iranian boats, and oil prices jumped before easing this morning; the Dow fell more than 550 points in its worst day in over a month. Palantir delivered 85% revenue growth and raised full-year adjusted free cash flow guidance to $4.2 billion-$4.4 billion, while Amazon's new logistics initiative pressured UPS and FedEx shares by more than 10% and 9%. The SEC also agreed to settle its Tesla case with Elon Musk for $1.5 million, and Amazon CEO Andy Jassy reiterated the company should benefit from heavy AI spending.

Analysis

The market is pricing two very different regimes at once: a near-term geopolitical shock that lifts energy and a medium-term disinflation/deflation impulse from logistics disruption and competitive overhang in transport. If Strait of Hormuz risk stays elevated, the first-order winners are obvious, but the second-order effect is that freight-sensitive margins elsewhere get squeezed before consumers fully feel higher pump prices. That makes the recent selloff in transport names potentially less about Amazon-specific disruption and more about the market rapidly repricing an entire cost stack that is more fragile than headline CPI implies.

Palantir’s print is important less for the beat itself and more for the evidence that federal AI budgets are moving from pilot to procurement at a scale that can sustain multiple quarters of 70%+ growth. The key second-order read-through is to defense software, systems integrators, and adjacent data/security vendors: once one platform demonstrates operating leverage, procurement officers tend to bundle follow-on awards, which can create a multi-quarter air pocket for laggards. The risk is valuation compression if growth normalizes even modestly; the stock is now trading on a narrative that needs continued acceleration, not just durable growth.

Amazon’s logistics move is a structural threat to UPS and FedEx because it attacks the most valuable part of their moat: density, routing, and last-mile utilization. The market is likely still underestimating how quickly third-party shippers will test Amazon as a lower-cost alternative in a softer freight environment, which could pressure pricing before outright volume loss becomes visible. This is a margin war, not just a share war, and incumbents may be forced into discounting to defend account retention over the next 2-3 quarters.

On healthcare, the pill adoption signal is more important than the brand-level comparison: if oral GLP-1s broaden the addressable market, volume could outrun fears about cannibalization. The contrarian view is that the market may be over-penalizing managed care on incomplete medical cost data just as utilization visibility is improving; if Q2 claims trends stabilize, the setup becomes a relief rally rather than a structural rerating. Meanwhile, Tesla’s litigation overhang appears less material than sentiment suggests, but it does not change the core issue that the stock still trades as a macro AI/liquidity proxy rather than a car company.

Key Decisions for Investors

• Short UPS / FDX on a 2-6 week horizon into any bounce; risk/reward favors further multiple compression if Amazon third-party logistics adoption becomes a real pipeline story. Stop if management commentary shows no rate pressure by next earnings cycle.
• Add PLTR on pullbacks for a 3-9 month horizon; use call spreads rather than common to express continued federal AI monetization with defined downside. The trade works if revenue growth remains above 50% and guidance keeps stepping higher.
• Put on a pair: long AMZN, short UPS or FDX, as a relative-margin winner/loser trade over the next 1-2 quarters. The thesis is that Amazon can subsidize logistics expansion with broader ecosystem economics while incumbents cannot.
• Consider a tactical long on NVO vs. a hedge basket of UNH/CI if oral GLP-1 adoption keeps accelerating; 3-6 month horizon. This captures category expansion while limiting exposure to payer utilization noise.
• Avoid chasing TSLA on the settlement headline; if anything, use strength to sell upside calls for income, since the legal event is unlikely to change the stock’s primary macro-driven trading regime.